Hims & Hers faces FTC lawsuit over privacy, stock drops 14% amid investor losses and legal probe.

Hims & Hers Health, Inc. is under investigation after the Federal Trade Commission sued the company for allegedly sharing customers' medical data with third-party advertisers like Snap and Meta Platforms. The lawsuit accuses Hims & Hers of deceptive and unlawful privacy practices. Following the news, Hims & Hers' stock price fell more than 14%, prompting a securities litigation law firm to investigate potential investor losses and legal rights. Investors who suffered losses may have claims under federal securities laws and are encouraged to contact the law firm for legal advice.